BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 29519533)

  • 1. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens.
    Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q
    Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
    Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
    PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    Manoharan VK; Varghese BP; Paldurai A; Samal SK
    PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding.
    Xu X; Ding Z; Yuan Q; Ding J; Li J; Wang W; Cong Y; Ouyang W; Wang Y; Qian J; Yin R
    Vaccine; 2019 Jan; 37(3):444-451. PubMed ID: 30545716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
    Liu H; de Almeida RS; Gil P; Majó N; Nofrarías M; Briand FX; Jestin V; Albina E
    Vaccine; 2018 Jun; 36(27):3917-3925. PubMed ID: 29843999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs.
    Hu Z; Hu S; Meng C; Wang X; Zhu J; Liu X
    Avian Dis; 2011 Sep; 55(3):391-7. PubMed ID: 22017036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
    Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
    J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune effect of a Newcastle disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation.
    Xie P; Li Y; Li Y; Liang J; Xiang B; Lin Q; Jin J; Ding C; Xu C; Ren T
    Arch Virol; 2020 Sep; 165(9):1959-1968. PubMed ID: 32519007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the safety and protection efficacy of an attenuated genotype vii newcastle disease virus strain as a candidate vaccine.
    Xu X; Li J; Ding J; Yang M; Xue C; Wang J; Cong Y; Yin R; Qian J; Jin N; Ding Z
    Microb Pathog; 2020 Feb; 139():103831. PubMed ID: 31682996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
    Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
    Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and evaluation of a genetically attenuated Newcastle disease virus rGM-VIIm as a genotype-matched vaccine.
    Sun M; Xiang B; Li Y; Xie P; Gao S; Kang Y; Gao P; Li Y; Wang Z; Liang J; Yu D; Ren T
    Virus Genes; 2017 Feb; 53(1):35-43. PubMed ID: 27718047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
    Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
    Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
    Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.